Available Technology

Intracranial Hematoma Detector

A common result of head injury, which leads to complications and sometimes to death, is blood and cerebral fluid pooling between the skull and the brain. Victims of blood pooling, or hematomas, can go for hours or days without presenting clear symptoms of the developing hematoma, yet coma and eventually disability or death can result from the pressure on the brain or brain stem. There is also a ten times greater chance that a head injury victim with a hematoma will die if surgery is delayed by more than 4 hours, but currently expensive, non-portable Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scans are the diagnostic tools. Portable intracranial hematoma detectors would offer medical personnel a tool to use immediately at the scene of an injury, in the ER, in urgent care facilities, or in home healthcare settings. Such detectors could help triage accident victims by facilitating the rapid determination of the extent of cranial injuries. Also, the screening by the detector could reduce the need for CT scans, minimizing unnecessary exposure to x-ray radiation. In addition, such detectors could also provide a convenient means to monitor the growth of a hematoma. The use of this device could decrease health care costs and improve patient outcomes associated with testing and treating cranial injuries. Earlier detection could potentially reduce the costs of patient rehabilitation and convalescence and reduce the morbidity resulting from current treatment time delays.
Patent Abstract: 
The patented intracranial hematoma detection technology uses Micropower Impulse Radar (MIR). MIR uses short, high frequency electromagnetic pulses to obtain information in a non-invasive manner.
Internal Laboratory Ref #: 
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin